 | | Enter your zip to find stuff near you | |
|
|
| | | This classified ad has expiredClick here to view current advertisements similar to this one.
Profile of 4 Life Science Venture Capital FundsLife science sector is the most invested sector in North America and Europe in 2010 & for many months in 2011, here are some companies worth considering. Alley Ventures LLCAlley Ventures LLC was created due the lack of early stage funding for emerging companies in medical technology, bioscience, and the broader life sciences. Alley Ventures has an excellent opportunity to provide strong returns to its investors and to act as an accelerator to help portfolio companies mature more quickly and gain market entry sooner. The company invests exclusively in early stage life science opportunities, ranging from biotechnology, R&D and medical devices. The Alliance of AngelsSince 1997, the Alliance of Angels (AoA) has connected a community of over 100 investors with the most promising early-stage companies in the Northwest to invest, mentor and enable their success. The AoA has provided over $60 million of early funding for more than 160 Northwest entrepreneurs over the last dozen years and celebrated more than 25 exits, making the AoA one of the preeminent angel groups in the world.Altitude Life Science VenturesIts investment experience and intellectual property expertise have been developed over 20 years and involvement in over 60 life science companies. The company specializes in investing and developing new IP ideas, from planning to product developments. Investment ranges from $1m to $2.5m in initial investments.TVM CapitalWith over EUR 1 billion under management, TVM Capital focuses on information technology and life sciences. Funds have made investments in 200 technology companies in Europe and the US. TVM Capital is headquartered in Germany and is one of the largest venture capital investor in the life-science sectors; recent investments include medical devices, e-health and other biotechnology R&D companies. The TVM Capital Life Science & Healthcare Practice currently manages €860 million (US$1.3bn) of committed capital from more than 50 investors.Looking for venture capital investors for your biotechnology / life-science investors? Please check our Global Biotechnology Capital Providers Guide on [please contact me for website address] | | | | | | |  | | | | |
|
